Advance financial reports | 18 August 2025 09:30

SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

SCHOTT Pharma AG & Co. KGaA / Preliminary announcement on the disclosure of financial statements
SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

18.08.2025 / 09:30 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

SCHOTT Pharma AG & Co. KGaA hereby announces that the following financial reports shall be disclosed:

Report Type: Financial report of the group (half-year/Q2)

Language: German
Date of disclosure: May 13, 2026
Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen

Language: English
Date of disclosure: May 13, 2026
Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations

18.08.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language:	English
Company:	SCHOTT Pharma AG & Co. KGaA
	Hattenbergstraße 10
	55122 Mainz
	Germany

End of News EQS News Service

2185086  18.08.2025 CET/CEST